TENAX THERAPEUTICS, INC.
Company Stats
- Market Cap
- $70.7M
- as of Sep 30, 2026
- Shares Outstanding
- 45.5M
- Free Float
- 79.0%
Income Statement
- Revenue
- $0
- Operating Income
- -$56.4M
- Net Income
- -$52.6M
Balance Sheet
- Cash & Equivalents
- $97.6M
Returns & Capital
- SBC, 3Y Avg
- $6.8M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $0 | — | — |
| FY2024 | $0 | — | — |
| FY2022 | — | -$11.4M | — |
| FY2021 | — | -$10.9M | — |
Annual filing data through FY ended December 31, 2025; shares and float as of November 6, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges
Healthcare Earnings: Demand Surges, Costs Bite Back